JP2013529600A5 - - Google Patents

Download PDF

Info

Publication number
JP2013529600A5
JP2013529600A5 JP2013514392A JP2013514392A JP2013529600A5 JP 2013529600 A5 JP2013529600 A5 JP 2013529600A5 JP 2013514392 A JP2013514392 A JP 2013514392A JP 2013514392 A JP2013514392 A JP 2013514392A JP 2013529600 A5 JP2013529600 A5 JP 2013529600A5
Authority
JP
Japan
Prior art keywords
gly
asp
ala
pharmaceutical composition
peptide derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2013514392A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013529600A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/040006 external-priority patent/WO2011156729A2/en
Publication of JP2013529600A publication Critical patent/JP2013529600A/ja
Publication of JP2013529600A5 publication Critical patent/JP2013529600A5/ja
Withdrawn legal-status Critical Current

Links

JP2013514392A 2010-06-11 2011-06-10 放射の影響を軽減し、及び全身性感染症のリスクを減少させる方法 Withdrawn JP2013529600A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35406710P 2010-06-11 2010-06-11
US61/354,067 2010-06-11
PCT/US2011/040006 WO2011156729A2 (en) 2010-06-11 2011-06-10 Methods of mitigating effects of radiation and reducing the risk of systemic infection

Publications (2)

Publication Number Publication Date
JP2013529600A JP2013529600A (ja) 2013-07-22
JP2013529600A5 true JP2013529600A5 (https=) 2014-07-17

Family

ID=44533067

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013514392A Withdrawn JP2013529600A (ja) 2010-06-11 2011-06-10 放射の影響を軽減し、及び全身性感染症のリスクを減少させる方法

Country Status (5)

Country Link
EP (1) EP2579891A2 (https=)
JP (1) JP2013529600A (https=)
AU (1) AU2011265228A1 (https=)
CA (1) CA2802176A1 (https=)
WO (1) WO2011156729A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021207411A1 (en) * 2020-04-07 2021-10-14 Chrysalis Biotherapeutics Tp508 acute therapy for patients with respiratory virus infection

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352664A (en) * 1986-10-31 1994-10-04 Board Of Regents, The University Of Texas System Thrombin derived polypeptides; compositions and methods for use
EP1539214A4 (en) 2002-07-02 2008-01-02 Orthologic Corp Thrombin
AU2003247848B2 (en) 2002-07-02 2006-12-21 The Board Of Regents, The University Of Texas System Thrombin peptide derivative dimers
US7294596B2 (en) 2005-03-14 2007-11-13 Diamorph Ceramic Ab Sintered ceramic material with improved properties and method for its manufacturing
CN101563102B (zh) * 2006-09-22 2014-12-17 德克萨斯系统大学董事会 治疗内皮功能障碍的方法
EP2155234A1 (en) * 2007-04-10 2010-02-24 The Board of Regents,The University of Texas System Combination therapy for chronic dermal ulcers

Similar Documents

Publication Publication Date Title
KR102285377B1 (ko) 글루카곤, glp-1 및 gip 수용체 모두에 활성을 갖는 삼중 활성체
US10245297B2 (en) Inhibitors of mitochondrial fission and methods of use thereof
JP2015504052A5 (https=)
JP2015509950A5 (https=)
RU2017119773A (ru) Пептидные антагонисты пептидных гормонов из семейства кальцитонина (cgrp) и их применение
JP2010536333A5 (https=)
IN2012DN02981A (https=)
JP2014506450A5 (https=)
CN106232616A (zh) 两亲性合成抗菌肽、其药物组合物及其用途
JP2019533722A5 (https=)
JP2019525753A5 (https=)
WO2012174397A3 (en) Anti-inflammatory pharmaceutical products
O’Reilly et al. Angiotensin-converting enzyme defines matrikine-regulated inflammation and fibrosis
WO2015086686A3 (en) Protease resistant peptides
JP2012516693A5 (https=)
JP2011528334A (ja) 哺乳動物のベータ・ディフェンシンを用いた、関節リウマチの治療
JP2006514822A5 (https=)
CN110831957B (zh) Apoc-ii模拟肽
KR20210010931A (ko) 집먼지진드기 알레르기의 치료 및 예방
WO2010103515A3 (en) Compositions and methods for prevention and treatment of neurodegenerative diseases
EP4028038A1 (en) Peptide-based compositions and methods for treating alzheimer's disease
JP2019038772A5 (https=)
JP2013529600A5 (https=)
JP2011515471A5 (https=)
WO2017149098A1 (en) Fusion respiratory syncytial virus inhibitors and use thereof